APF
HZNP

Alaska Permanent Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Alaska Permanent Fund’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$103K Sell
904
-102
-10% -$8.47K ﹤0.01% 344
2022
Q3 		$62K Sell
1,006
-183
-15% -$12.8K ﹤0.01% 356
2022
Q2 		$95K Buy
+1,189
New +$113K ﹤0.01% 349

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alaska Permanent Fund's HZNP Position: Q4 2022 in Review

Alaska Permanent Fund reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 10% in Q4 2022, selling an estimated $8.47K and leaving 904 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Alaska Permanent Fund first reported a position in HZNP in Q2 2022 and has held it in 3 quarters since. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Alaska Permanent Fund held 904 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $103K as of Q4 2022.
  • Alaska Permanent Fund sold 102 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $8.47K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Alaska Permanent Fund's portfolio in Q4 2022, its #344 holding.
  • Alaska Permanent Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and has held it in 3 quarters since.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Alaska Permanent Fund's 13F filing for Q4 2022, filed 8 Feb 2023.